216 related articles for article (PubMed ID: 36068474)
1. Pharmacogenomics of Opioid Treatment for Pain Management.
Howes S; Cloutet AR; Kweon J; Powell TL; Raza D; Cornett EM; Kaye AD
Methods Mol Biol; 2022; 2547():491-504. PubMed ID: 36068474
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.
Lloyd RA; Hotham E; Hall C; Williams M; Suppiah V
Pain Med; 2017 Dec; 18(12):2369-2387. PubMed ID: 28339912
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and prescription opioid use.
Benjeddou M; Peiró AM
Pharmacogenomics; 2021 Mar; 22(4):235-245. PubMed ID: 33445954
[TBL] [Abstract][Full Text] [Related]
5. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
6. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
7. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of opioids and perioperative pain management.
Sadhasivam S; Chidambaran V
Pharmacogenomics; 2012 Nov; 13(15):1719-40. PubMed ID: 23171337
[TBL] [Abstract][Full Text] [Related]
9. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of chronic pain management.
Kapur BM; Lala PK; Shaw JL
Clin Biochem; 2014 Sep; 47(13-14):1169-87. PubMed ID: 24912048
[TBL] [Abstract][Full Text] [Related]
11. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.
Rauck RL
Pain Pract; 2019 Apr; 19(4):443-454. PubMed ID: 30597739
[TBL] [Abstract][Full Text] [Related]
12. The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant Pain.
Lipman A; Webster L
J Manag Care Spec Pharm; 2015 Oct; 21(10):891-9. PubMed ID: 26402389
[TBL] [Abstract][Full Text] [Related]
13. The Role of Pharmacogenomics in Postoperative Pain Management.
Sachtleben EP; Rooney K; Haddad H; Lassiegne VL; Boudreaux M; Cornett EM; Kaye AD
Methods Mol Biol; 2022; 2547():505-526. PubMed ID: 36068475
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.
Cornett EM; Carroll Turpin MA; Pinner A; Thakur P; Sekaran TSG; Siddaiah H; Rivas J; Yates A; Huang GJ; Senthil A; Khurmi N; Miller JL; Stark CW; Urman RD; Kaye AD
Curr Oncol Rep; 2020 Feb; 22(2):18. PubMed ID: 32030524
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of opioids.
Somogyi AA; Barratt DT; Coller JK
Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
[TBL] [Abstract][Full Text] [Related]
16. "My life is under control with these medications": an interpretative phenomenological analysis of managing chronic pain with opioids.
Ljungvall H; Rhodin A; Wagner S; Zetterberg H; Åsenlöf P
BMC Musculoskelet Disord; 2020 Jan; 21(1):61. PubMed ID: 32005212
[TBL] [Abstract][Full Text] [Related]
17. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy.
Lewandrowski KU; Sharafshah A; Elfar J; Schmidt SL; Blum K; Wetzel FT
Cell Mol Neurobiol; 2024 May; 44(1):47. PubMed ID: 38801645
[TBL] [Abstract][Full Text] [Related]
18. Combating opioid addiction and abuse-2 ways to effectively intervene in the cycle of addiction through pharmacogenomics.
J Marcalus S; Bristow-Marcalus S
J Am Pharm Assoc (2003); 2019; 59(4):469-473. PubMed ID: 31126828
[TBL] [Abstract][Full Text] [Related]
19. Management of Patients with a Musculoskeletal Pain Condition that is Likely Chronic: Results from a National Cross Sectional Survey.
Feldman DE; Carlesso LC; Nahin RL
J Pain; 2020; 21(7-8):869-880. PubMed ID: 31837448
[TBL] [Abstract][Full Text] [Related]
20. The Social and Functional Implications of High- Versus Low-Dose Opioids on Chronic Non-Cancer Pain.
Denawa Y; Kurtz W; Conermann T
Pain Physician; 2019 Jul; 22(4):401-411. PubMed ID: 31337176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
